ADEM MAMAN

Dr. ADEM MAMAN

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in Computational Systems and Artificial Intelligence
Verified
Journal Article
Open access
PDF file
YÇYiğitcan Çakmak
Yiğitcan Çakmak
AMADEM MAMAN
ADEM MAMAN
Early diagnosis of lung cancer is critical for improving patient prognosis. While Computer-Aided Diagnosis (CAD) systems leveraging deep learning have shown promise, the selection of an optimal model architecture remains a key challenge. This study presents a comparative analysis of three prominent Convolutional Neural Network (CNN) architectures InceptionV4, VGG-13, and ResNet-50 to determine their effectiveness in classifying lung cancer into benign, malignant, and normal categories from Computed Tomography (CT) images. Utilizing the publicly available IQ-OTH/NCCD dataset, a transfer learning approach was employed, where models pre-trained on ImageNet were fine-tuned for the specific classification task. To mitigate overfitting and enhance model generalization, a suite of data augmentation techniques was applied during training. It achieved an accuracy of 98.80%, with a precision of 98.97%, a recall of 96.30%, and an F1-score of 97.52%. Notably, the confusion matrix analysis revealed that InceptionV4 perfectly identified all malignant and normal cases in the test set, highlighting its clinical reliability. The study also evaluated the trade-off between diagnostic performance and computational efficiency, where InceptionV4 provided an optimal balance compared to the computationally intensive VGG-13 and the less accurate, albeit more efficient, ResNet-50. Our findings suggest that the architectural design of InceptionV4, with its multi-scale feature extraction, is exceptionally well-suited for the complexities of lung cancer diagnosis. This model stands out as a robust and highly accurate candidate for integration into clinical CAD systems, offering significant potential to assist radiologists and improve early detection outcomes.

30 January 2024 in EJNMMI Reports
Verified
Journal Article
Open access
PDF file
AMADEM MAMAN
ADEM MAMAN
SÇSadık Çiğdem
Sadık Çiğdem
IKİdRis Kaya
İdRis Kaya
RDRabia Demirtaş
Rabia Demirtaş
OCOnur Ceylan
Onur Ceylan
SÖSevilay Özmen
Sevilay Özmen
Background: Lung cancer is the leading cause of cancer-related deaths worldwide. The combination of fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) and computed tomography (CT) has a major impact on the diagnosis, staging, treatment planning and follow-up of lung cancer patients. The maximum standardized uptake value (SUVmax) is an easily performed and most widely used semi-quantitative index for the analysis of FDG PET images and estimation of metabolic activity. This study aimed to investigate the role of PET/CT in differentiating adenocarcinoma (ADC), the most common lung cancer, from squamous cell carcinoma (SCC) by comparing FDG uptake measured as SUVmax. Results: Between 2019 and 2022, 76 patients diagnosed with non-small cell lung cancer (NSCLC) at the Department of Pathology, Atatürk University Faculty of Medicine, with histopathologic evidence of adenocarcinoma or squamous cell carcinoma, underwent retrospective analysis using PET/CT scanning to measure PET parameters of the lesions and compare them with histopathology. Among 76 NSCLC patients included in the study, 43 (57%) were histopathologically diagnosed as ADC and 33 (43%) as SCC. SUVmax, SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) values of lesions in patients with SCC were statistically significantly higher than those in patients with ADC (p values 0.007, 0.009, 0.003 and 0.04, respectively). Conclusions: Lung SCC has higher metabolic uptake values than ADC, and PET/CT can be used to differentiate them.

1 February 2016 in Journal of Surgical Research
Verified
Journal Article
Closed access
ÖÇÖznur Dilek Çiftçi
Öznur Dilek Çiftçi
SGSerdar Savaş Gül
Serdar Savaş Gül
KAKurtuluş Açıksarı
Kurtuluş Açıksarı
AMADEM MAMAN
ADEM MAMAN
TÇTürker Çavuşoğlu
Türker Çavuşoğlu
OEOytun Erbaş
Oytun Erbaş

19 November 2024 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Closed access
PDF file
AMADEM MAMAN
ADEM MAMAN
IPIshak Pacal
Ishak Pacal
Fatih BATIFatih BATI
Fatih BATI

23 November 2021 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
ZKZerrin Kutlu
Zerrin Kutlu
ABArzu Bilen
Arzu Bilen
MÇMuhammet Çelik
Muhammet Çelik
AMADEM MAMAN
ADEM MAMAN
MGMine Gulaboglu
Mine Gulaboglu
ZHzekai halici
zekai halici
Objectives: Our aim is to explain the relationship between Ang II and Scl in osteoporotic (OP) rats and the contribution of Scl in the antiosteoporotic effect mechanism of angiotensin receptor blockers (ARB). Methods: This study consists of two sub-studies conducted on 4th and 12th weeks after ovariectomy. In study 1, treatment was started immediately after bilateral ovariectomy (OVX), while, in study 2, treatment was started 2 months after OVX. Two different doses of telmisartan (5 and 10 mg/kg) were administered with the aid of gavage for 30 days in both sub-study groups. Results: Serum and tissue Scl, osteocalcin, osteopontin and tartrate-resistant acid phosphatase mRNA expressions were higher and bone mineral densities (BMD) and bone-specific alkaline phosphatase (BALP) mRNA expressions were found to be lower in the OVX groups compared with the sham group. In OVX groups where two different doses of telmisartan were administered, BMD and BALP mRNA expressions increased and serum and tissue Scl decreased. Conclusion: There may be a close relationship between angiotensin II and sclerostin in the development of osteoporosis. In this study, telmisartan administration showed an antiosteoporotic effect and significantly decreased the level of sclerostin. These results strongly support this relationship.

23 January 2024 in Nuklearmedizin-Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
AMADEM MAMAN
ADEM MAMAN
In this study, we present in detail a case of a thyroid nodule presenting with gastric neuroendocrine tumor (NET), which was incidentaly detected during a Gallium-68 (Ga-68) DOTATATE positron emission tomography/computed tomography (PET/CT) scan for staging and subsequently identified as papillary thyroid carcinoma on pathological examination. This rare case demonstrates that DOTATATE uptake can occur not only in NETs but also in thyroid cancers. This study emphasizes the importance of Fine Needle Aspiration Biopsy (FNA), especially in incidental thyroid nodules. It also highlights the place of Ga-68 DOTATATE PET/CT in clinical practice and the importance of further research in this field. Received: 12 December 2023 Accepted: 03 January 2024 Article published online: 23 January 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany